These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38051436)

  • 21. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
    In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
    Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
    Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.
    Wang L; Wu X; Xu W; Gao L; Wang X; Li T
    Front Oncol; 2022; 12():713335. PubMed ID: 35280723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retrospective study of role of neoadjuvant rectal scores in evaluating the 10-year disease-free survival of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy followed by surgery].
    Zhang WL; Zhou C; Wang WF; Li WH; He JH; Lu ZH; Wu XJ; Lin JZ; Peng JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):608-614. PubMed ID: 38901994
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 28. T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
    Hayes IP; Milanzi E; Pelly RM; Gibbs P; Reece JC
    J Surg Oncol; 2022 Sep; 126(4):728-739. PubMed ID: 35635190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
    Huang X; Zheng Z; Zeng B; Xiao H; Zheng H; Lin Z; Song J; Li A; Chi P; Yang Y; Xu B; Zheng R
    BMC Cancer; 2023 Mar; 23(1):238. PubMed ID: 36918865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy.
    Arslan A; Akay E; Turk G; Eren SK
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: influencing factors and prognostic significance.
    Lu X; Qi R; Xu Y; Wang X; Cai Y; Wang C
    Int J Clin Exp Pathol; 2023; 16(6):124-132. PubMed ID: 37425225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion.
    Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F
    Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
    Wehrle CJ; Woo K; Chang J; Gamaleldin M; DeHaan R; Dahdaleh F; Felder S; Rosen DR; Champagne B; Steele SR; Naffouje SA
    J Surg Oncol; 2024 Apr; 129(5):945-952. PubMed ID: 38221655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of MRI Risk Stratification System on the Survival Benefits of Adjuvant Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Zhao R; Zhao W; Zhu Y; Wan L; Chen S; Zhao Q; Zhao X; Zhang H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S164-S175. PubMed ID: 37369619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.